Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:HSCS NASDAQ:HSDT OTCMKTS:USAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.12+1.8%$1.32$0.96▼$21.49$6.63M-2.97263,644 shs251,857 shsHSCSHeartSciences$3.41+0.3%$3.73$2.36▼$6.47$7.78M2.56108,202 shs7,670 shsHSDTHelius Medical Technologies$6.12-1.6%$8.17$5.37▼$1,200.00$6.59M0.7432,131 shs11,952 shsUSAQQHSLab$0.19$0.20$0.08▼$0.47$2.01M0.45876 shsN/ABeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%+10.89%-19.42%-32.12%-91.64%HSCSHeartSciences0.00%-6.58%+11.80%-7.59%+0.29%HSDTHelius Medical Technologies0.00%-4.08%+0.33%-96.65%-98.93%USAQQHSLab0.00%0.00%-12.84%-2.56%+27.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.3336 of 5 stars3.32.00.00.01.71.71.3HSCSHeartSciences3.2949 of 5 stars3.55.00.00.03.80.80.6HSDTHelius Medical Technologies0.5587 of 5 stars0.02.00.00.03.30.80.6USAQQHSLabN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.67Moderate Buy$16.501,373.21% UpsideHSCSHeartSciences 3.00Buy$13.00281.23% UpsideHSDTHelius Medical Technologies 2.00HoldN/AN/AUSAQQHSLab 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest USAQ, HSCS, HSDT, and AMIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025AMIXAutonomix MedicalZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 9/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/AHSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/AHSDTHelius Medical Technologies$295K22.34N/AN/A$212.95 per share0.03USAQQHSLab$2.13M0.94N/AN/A($0.06) per share-3.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$5.74N/AN/AN/AN/A-172.93%-133.39%11/14/2025 (Estimated)HSCSHeartSciences-$8.77M-$9.36N/AN/AN/AN/A-293.60%-135.39%9/11/2025 (Estimated)HSDTHelius Medical Technologies-$11.74M-$1,976.28N/A∞N/A-7,215.25%-699.93%-415.24%11/10/2025 (Estimated)USAQQHSLab-$260K-$0.04N/A∞N/A-15.33%N/A-21.37%N/ALatest USAQ, HSCS, HSDT, and AMIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/11/2025N/AHSCSHeartSciences-$2.41N/AN/AN/AN/AN/A8/14/2025Q2 2025HSDTHelius Medical Technologies-$128.50-$79.73+$48.77-$79.73$0.11 million$0.04 million8/13/2025Q1 2026AMIXAutonomix Medical-$0.98-$1.07-$0.09-$1.07N/AN/A7/24/2025Q4 2025HSCSHeartSciences-$2.51-$1.88+$0.63-$1.88N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AHSCSHeartSciencesN/AN/AN/AN/AN/AHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.574.57HSCSHeartSciencesN/A0.590.41HSDTHelius Medical TechnologiesN/A4.323.69USAQQHSLabN/A0.160.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%HSCSHeartSciences17.24%HSDTHelius Medical Technologies18.63%USAQQHSLabN/AInsider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%HSCSHeartSciences1.80%HSDTHelius Medical Technologies17.90%USAQQHSLab74.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical15.92 million4.00 millionN/AHSCSHeartSciences102.28 million2.24 millionNot OptionableHSDTHelius Medical Technologies301.08 million884,000Not OptionableUSAQQHSLab510.59 million2.73 millionNot OptionableUSAQ, HSCS, HSDT, and AMIX HeadlinesRecent News About These CompaniesShort Interest in QHSLab, Inc. (OTCMKTS:USAQ) Expands By 45.5%August 21, 2025 | americanbankingnews.comQHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health ServicesJuly 8, 2025 | globenewswire.comQHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare EfficiencyJune 3, 2025 | globenewswire.comQHSLab Enters Advanced Talks for Debt RestructuringMay 16, 2025 | tipranks.comQHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive GrowthMay 16, 2025 | globenewswire.comInvesting in Smarter Healthcare: The New Era of AI-Driven MedicineMay 15, 2025 | theglobeandmail.comQHSLab, Inc. Reports 32% Year-Over-Year Revenue Growth and Expanded Gross Margins in First Quarter 2025May 15, 2025 | globenewswire.comUSA Equities Engages Hayden IR for Investor RelationsFebruary 26, 2025 | tipranks.comQHSLab, Inc. Engages Hayden IR to Launch Comprehensive Investor Relations ProgramFebruary 26, 2025 | globenewswire.comQHSLab’s Record Revenue Growth and First Profitable YearFebruary 18, 2025 | tipranks.comQHSLab, Inc. Reports Record Revenue Growth and Positive Net Income in Preliminary Q4 and FY 2024 Financial ResultsFebruary 18, 2025 | globenewswire.comQHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic GrowthFebruary 11, 2025 | globenewswire.comUSA Equities Highlights 2025 Corporate PresentationJanuary 21, 2025 | tipranks.comUSA Equities to Exhibit at Pri-Med South ConferenceJanuary 16, 2025 | tipranks.comUSA Equities Outlines Growth Strategy Amid ChallengesDecember 17, 2024 | markets.businessinsider.comQHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE TechnologyDecember 13, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Marks Major Achievements in Digital Health Innovation, Research Recognition, and Revenue Growth in 2024November 25, 2024 | globenewswire.comQHSLab, Inc. (OTCQB: USAQ) Reports Record Q3 2024 Revenues, Reflecting Accelerated Expansion in Digital Health and Allergy DiagnosticsNovember 14, 2024 | globenewswire.comUS election latest: Harris set to give first speech since Trump's election winNovember 7, 2024 | news.sky.comNThe US city run by Muslim AmericansOctober 26, 2024 | bbc.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUSAQ, HSCS, HSDT, and AMIX Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.12 +0.02 (+1.82%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.10 -0.02 (-1.79%) As of 08/29/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.HeartSciences NASDAQ:HSCS$3.41 +0.01 (+0.29%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$3.30 -0.12 (-3.37%) As of 08/29/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Helius Medical Technologies NASDAQ:HSDT$6.12 -0.10 (-1.61%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$6.19 +0.07 (+1.21%) As of 08/29/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.QHSLab OTCMKTS:USAQ$0.19 0.00 (0.00%) As of 08/29/2025QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
